DXCM
DexCom Inc
NASDAQ: DXCM · HEALTHCARE · MEDICAL DEVICES
$57.56
-2.97% today
Updated 2026-04-29
Market cap
$22.21B
P/E ratio
27.54
P/S ratio
4.76x
EPS (TTM)
$2.09
Dividend yield
—
52W range
$54 – $90
Volume
4.1M
DexCom Inc (DXCM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $64.55M | $77.26M | $44.37M | $46.95M | $77.16M | $120.47M | $106.00M | $122.50M | $184.60M | $292.00M | $402.80M | $904.10M | $1.92B | $2.40B | $4.29B | $4.93B | $5.39B | $6.26B | $6.48B | $6.34B |
| Cash & equivalents | $18.17M | $23.11M | $12.70M | $3.58M | $4.89M | $2.55M | $8.10M | $43.20M | $71.80M | $86.10M | $94.50M | $441.50M | $1.14B | $446.20M | $817.60M | $1.05B | $642.30M | $566.30M | $606.10M | $917.70M |
| Current assets | $57.36M | $67.29M | $32.06M | $36.92M | $66.03M | $104.41M | $77.60M | $93.10M | $145.90M | $231.30M | $280.00M | $744.70M | $1.70B | $1.97B | $3.42B | $3.68B | $3.67B | $4.43B | $4.30B | $4.03B |
| Total liabilities | $7.72M | $70.14M | $82.98M | $65.39M | $16.17M | $15.98M | $29.00M | $38.40M | $44.40M | $70.80M | $119.00M | $484.70M | $1.25B | $1.51B | $2.46B | $2.89B | $3.26B | $4.20B | $4.38B | $3.59B |
| Current liabilities | $5.23M | $8.45M | $15.00M | $18.80M | $15.13M | $14.74M | $19.50M | $32.10M | $40.60M | $66.90M | $102.40M | $138.90M | $222.40M | $360.20M | $614.10M | $720.80M | $1.84B | $1.56B | $2.93B | $2.14B |
| Long-term debt | $2.12M | $61.03M | $61.42M | $45.76M | — | $0.00 | $6.80M | $4.60M | $2.30M | $0.00 | $0.00 | $327.60M | $1.01B | $1.06B | $1.67B | $1.70B | $1.20B | $2.43B | $1.24B | $1.24B |
| Shareholder equity | $56.83M | $7.12M | $-19.47M | $-18.45M | $60.99M | $104.50M | $77.00M | $84.10M | $140.20M | $221.20M | $283.80M | $419.40M | $663.30M | $882.60M | $1.83B | $2.04B | $2.13B | $2.07B | $2.10B | $2.75B |
| Retained earnings | $-130.37M | $-176.25M | $-231.44M | $-291.21M | $-346.38M | $-391.12M | $-445.60M | $-475.40M | $-497.80M | $-555.40M | $-621.00M | $-671.80M | $-798.90M | $-695.70M | $-202.10M | $138.70M | $479.90M | $1.02B | $1.60B | $2.43B |
| Accounts receivable | $120000.00 | $215000.00 | $1.12M | $3.49M | $6.67M | $12.50M | $19.50M | $26.10M | $42.40M | $74.10M | $101.70M | $134.30M | $226.70M | $286.30M | $428.50M | $516.60M | $752.20M | $987.50M | $1.03B | $1.29B |
| Inventory | $1.41M | $1.14M | $2.45M | $2.64M | $8.11M | $8.17M | $7.40M | $9.00M | $16.00M | $35.20M | $45.40M | $45.20M | $70.70M | $119.80M | $234.70M | $357.30M | $306.70M | $559.60M | $542.60M | $629.10M |
| Goodwill | — | — | — | — | — | $0.00 | $3.20M | $3.20M | $3.20M | $3.70M | $11.30M | $12.10M | $18.70M | $18.60M | $19.30M | $26.50M | $25.70M | $25.20M | $22.80M | $24.20M |